TP53 and Miyoshi myopathy: Specifically, MM in both species is characterized by progressively increased proliferation and decrease in immunoglobulin expression, APOBEC mutational activity, mutations in distinct driver genes (e.g. TP53), and by the intermediate acquisition of chromothripsis, structural variants, and focal copy numbers12,18,52.